QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
NASDAQ:CRBP

Corbus Pharmaceuticals News Headlines

$0.50
-0.04 (-7.41%)
(As of 01/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.50
$0.55
50-Day Range
$0.51
$1.11
52-Week Range
$0.50
$4.00
Volume
714,512 shs
Average Volume
752,728 shs
Market Capitalization
$62.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.73
Get Corbus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Corbus Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRBP
News Sentiment

-0.53

0.33

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRBP Articles
This Week

2

1

CRBP Articles
Average Week



Corbus Pharmaceuticals (NASDAQ:CRBP) News Headlines Today

SourceHeadline
marketbeat.com logoZacks Investment Research Upgrades Corbus Pharmaceuticals (NASDAQ:CRBP) to Buy
marketbeat.com - January 17 at 4:23 PM
msn.com logoCannabis Stock Gainers And Losers From January 12, 2022
msn.com - January 12 at 8:09 PM
msn.com logoCannabis Stock Gainers And Losers From January 6, 2022
msn.com - January 6 at 6:53 PM
finance.yahoo.com logoHere's Why You Should Hold Onto Acadia Healthcare (ACHC) Now
finance.yahoo.com - December 31 at 1:50 PM
msn.com logoAfter Plunging 29.4% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)
msn.com - December 29 at 11:24 AM
finance.yahoo.com logoDown 31.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Corbus Pharmaceuticals (CRBP)
finance.yahoo.com - December 7 at 2:20 PM
marketwatch.com logoCorbus Pharmaceuticals Holdings Inc. stock rises Friday, still underperforms market
marketwatch.com - November 13 at 8:34 AM
finance.yahoo.com logoCorbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
finance.yahoo.com - November 12 at 9:49 AM
marketwatch.com logoCorbus Pharmaceuticals Holdings Inc. stock outperforms market on strong trading day
marketwatch.com - November 8 at 8:08 PM
finance.yahoo.com logoWill Corbus Pharmaceuticals (CRBP) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - November 2 at 7:58 PM
finance.yahoo.com logoCorbus Pharmaceuticals Completes $27.2 Million Registered Direct Offering
finance.yahoo.com - October 26 at 7:37 AM
finance.yahoo.com logouniQure Announces the Appointment of Rachelle Jacques to its Board of Directors
finance.yahoo.com - October 21 at 10:17 AM
finance.yahoo.com logoCould The Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - September 10 at 7:57 AM
benzinga.com logoRecap: Corbus Pharmaceuticals Q2 Earnings
benzinga.com - August 12 at 4:30 PM
finance.yahoo.com logoCorbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
finance.yahoo.com - August 12 at 4:30 PM
finance.yahoo.com logoCorbus Pharmaceuticals (CRBP) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 12 at 4:30 PM
finance.yahoo.com logoCorbus Pharmaceuticals (CRBP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - July 29 at 5:41 PM
nasdaq.com logoCorbus Pharmaceuticals Holdings, Inc. Common Stock (CRBP)
nasdaq.com - July 23 at 6:58 PM
bizjournals.com logoCorbus shares fall as autoimmune drug fails another late-stage trial
bizjournals.com - June 24 at 2:29 PM
markets.businessinsider.com logoCorbus Says DETERMINE Phase 3 Study Of Lenabasum Did Not Meet Primary Endpoint - Quick Facts
markets.businessinsider.com - June 24 at 9:28 AM
finance.yahoo.com logoCorbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
finance.yahoo.com - June 24 at 9:28 AM
finance.yahoo.com logoIs Corbus Pharmaceuticals Holdings Inc (CRBP) A Good Stock To Buy?
finance.yahoo.com - June 21 at 10:27 PM
nasdaq.com logoIs Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) A Risky Investment?
nasdaq.com - June 12 at 8:02 PM
finance.yahoo.com logoWe Think Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) CEO Compensation Package Needs To Be Put Under A Microscope
finance.yahoo.com - June 12 at 10:02 AM
finance.yahoo.com logoDoes Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Have A Healthy Balance Sheet?
finance.yahoo.com - June 3 at 9:35 AM
finance.yahoo.com logoCorbus In-Licenses Two Anti-Integrin Antibodies Targeting Cancer, Fibrotic Diseases Settings
finance.yahoo.com - June 1 at 7:16 PM
finance.yahoo.com logoCorbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic Diseases
finance.yahoo.com - June 1 at 9:16 AM
finance.yahoo.com logoCorbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2021 Virtual Congress
finance.yahoo.com - May 25 at 11:20 AM
finance.yahoo.com logoCORBUS PHARMACEUTICALS ANNOUNCES ADJOURNMENT OF ANNUAL MEETING
finance.yahoo.com - May 19 at 2:18 PM
seekingalpha.com logoCorbus Pharmaceuticals EPS in-line, misses on revenue
seekingalpha.com - May 15 at 8:52 AM
markets.businessinsider.com logoCorbus Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Updates
markets.businessinsider.com - May 13 at 8:31 AM
finance.yahoo.com logoCorbus Pharmaceuticals to Present at Three Upcoming Investor Conferences
finance.yahoo.com - May 11 at 10:21 AM
finance.yahoo.com logoCorbus Pharmaceuticals (CRBP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - May 3 at 6:14 PM
finance.yahoo.com logoCorbus Pharmaceuticals Announces Completion of Enrollment in NIH-Sponsored Phase 2 Study of Lenabasum for Treatment of Systemic Lupus Erythematosus (SLE)
finance.yahoo.com - April 20 at 12:59 PM
finance.yahoo.com logoCorbus Pharmaceuticals Reports Last Subject Visit in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
finance.yahoo.com - March 30 at 10:35 AM
seekingalpha.com logoCorbus Pharmaceuticals Holdings, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 17 at 1:28 PM
finance.yahoo.com logoCorbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2020 Earnings Call Transcript
finance.yahoo.com - March 15 at 5:58 PM
finance.yahoo.com logoRecap: Corbus Pharmaceuticals Q4 Earnings
finance.yahoo.com - March 15 at 12:58 PM
finance.yahoo.com logoCorbus Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results
finance.yahoo.com - March 15 at 7:58 AM
247wallst.com logoEarnings Previews: Corbus Pharmaceuticals, Yalla
247wallst.com - March 11 at 1:53 PM
finance.yahoo.com logoHave Insiders Been Buying Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares?
finance.yahoo.com - March 10 at 7:34 AM
benzinga.com logoCorbus Pharmaceuticals to Report Fourth Quarter...
benzinga.com - March 8 at 1:47 PM
finance.yahoo.com logoCorbus Pharmaceuticals to Report Fourth Quarter and Year-End 2020 Results on March 15, 2021
finance.yahoo.com - March 8 at 8:28 AM
finance.yahoo.com logoCorbus Pharmaceuticals (CRBP) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
finance.yahoo.com - March 4 at 1:40 PM
marketwatch.com logoCould These 4 Biotech Stocks See A Short Squeeze This Week?
marketwatch.com - February 24 at 5:27 PM
markets.businessinsider.com logoThe Week In Cannabis: Stocks Up By Double-Digits On Jazz Pharma's GWPH Acquisition, Potential Federal Moves
markets.businessinsider.com - February 5 at 6:30 PM
marketwatch.com logoThinking about buying stock in AMC Entertainment, Nokia, Corbus Pharmaceuticals, GameStop, or Microvision?
marketwatch.com - February 3 at 2:25 PM
uk.finance.yahoo.com logoCRBP Feb 2021 2.000 call
uk.finance.yahoo.com - January 24 at 11:10 PM
uk.finance.yahoo.com logoCRBP Feb 2021 1.000 call
uk.finance.yahoo.com - January 23 at 9:57 PM
uk.finance.yahoo.com logoCRBP Feb 2021 0.500 call
uk.finance.yahoo.com - January 23 at 4:56 PM
stocknews.com logoShould Corbus Pharmaceutical Holdings Be In Your Cannabis Stock Portfolio?
stocknews.com - January 22 at 11:11 AM
Get Corbus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.